SENS News and Press, Senseonics Holdings Inc. From 11/09/23

2023-11-09 16:13:29 ET More on Senseonics Senseonics enters a $50M loan facility DexCom cites rising glucose monitor use amid weight loss therapy Seeking Alpha’s Quant Rating on Senseonics Historical earnings data for Senseonics Financial infor...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended September 30, 2023. ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Stifel 2023 Healthcare Co...

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its third quarter 2023 financial resu...

Almost 1 in 2 people with diabetes using a short-term CGM are not fully satisfied with their current system i Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manu...

Study Data to Support FDA Submission for the first 365-day Continuous Glucose Monitoring System Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) system...

2023-09-11 14:22:11 ET Penny stocks priced under $1 per share have attracted a dedicated following among traders seeking massive returns. While penny stocks are inherently high-risk investments, the potential reward with these low-priced shares is exponentially higher compared to tradit...

2023-09-11 09:01:31 ET More on Senseonics Financial information for Senseonics Senseonics Faces Headwinds In Competitive CGM Market Senseonics begun at underperform at Jefferies on glucose monitoring market For further details see: Senseonics enters a $50...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has entered into a $50 million loan facility with Herc...

2023-09-06 13:47:07 ET More on Abbott, DexCom, etc. Compare metrics for ABT to DXCM, MDT, SENS Medtronic: The Crossroads Of Its Growth Trajectory Medtronic: The Tide Is Turning Medtronic: Dark Clouds Are Clearing - Outperformance Ahead Senseonics Face...